M vs REGN · P/E 6.4, rev $23.01B vs P/E 14, rev $14.34B
Macy’s Inc (M) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Macy’s Inc (M) is a department stores company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported M revenue for 2025-02-01 was $23.01B. Net income was $582.0M. Revenue was down 3.6% from 2024-02-03 to 2025-02-01. M currently screens at market cap $3.46B and trailing P/E 6.4.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
M currently screens at market cap $3.46B and trailing P/E 6.4. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the M and REGN stock pages for the full models.
Not investment advice.